Merck KGaA, Darmstadt, Germany

Model 53202-U - SupelMIP Beta-agonists (class selective) 25 mg / 10 mL

From

0
A class selective MIP phase for the multi-residue extraction of beta-agonists in urine, tissues, and other biological fluids. SupelMIP - Beta-agonists was developed for the selective extaction of a broad range o beta-agonists such as brombuterol, clenbuterol, formoterol, isoxuprine, mapenterol, ractopamine, ritrodine, salbutamol, salmeterol, terbutaline, tulobuterol, zilpaterol and others. The SupelMIP cartridge offers excellent reproducibility for surveillance of this common class of drugs of abuse. Loading capacity is superior to immuno-affinity columns, and MS-detection is recommended for forensic validity. Detailed extraction protocols are included with the product. SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC

Image

· Achieve lower detection limits through superior selectivity
· Save time and reduce cost via robust and rapid methodology
· Stable at broad pH ranges and high temperatures
· Reduce ion suppression
· Stringent quality control conditions

Customer reviews

No reviews were found for Model 53202-U - SupelMIP Beta-agonists (class selective) 25 mg / 10 mL. Be the first to review!